Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of organic compounds known as 2-naphthalene sulfonic acids and derivatives. It is also referred to by the code name ZEN. The molecule has been studied primarily as an experimental inhibitor of serine proteases and has been co-crystallized in complex with trypsin and factor Xa in structural biology studies. There are no approved clinical indications or marketed products containing this compound. Its primary use appears to be as a research tool for studying protease inhibition mechanisms[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [4-(6-chloro-naphthalene-2-sulfonyl)-piperazin-1-yl]-(3,4,5,6-tetrahydro-2h-[1,4']bipyridinyl-4-yl)-methanone.